BICO Group logo

BICO Group(OM) BICO

Market CapSEK 1.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)+78%
5 Year-95%
1 Year+1%
1 Month+11%
SEK 24.25
-1.22%
-0.30Today
BICO Group last closing stock price
MetricPriceDate
Last closeSEK 24.252026-10-16
BICO Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.32%SEK 23.702026-10-09
1 month+11.49%SEK 21.752026-09-16
3 month+74.21%SEK 13.922026-07-17
Year to date+15.15%SEK 21.062025-12-30
1 year+1.21%SEK 23.962025-10-16
3 year-0.7%SEK 24.422023-10-17
5 year-94.93%SEK 478.202021-10-15
Since inception+77.98%SEK 13.632016-11-03

BICO Group Financials at a Glance

Market Cap

SEK 1.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 1.50B

Net Income (TTM)

-SEK 839.20M

EPS (TTM)

-SEK 11.89

P/E Ratio

-2.04

Dividend

SEK 0.00

Beta (Volatility)

1.45 (Average)

Price

SEK 24.25

Volume

390,260

Open

SEK 24.20

Previous Close

SEK 24.55

Daily Range

SEK 24.20 - SEK 25.35

52-Week Range

SEK 12.94 - SEK 25.42

Estimated Earnings Date

Nov 11, 2026

BICO News

3D-bioprinter

How BICO Will Shape the Future of 3D Bioprinting

Motley Fool StaffJan 8, 2022
cash-flow-red

3 Red Flags Slowing BICO Stock's Growth

Motley Fool StaffJan 7, 2022
acquisition

Why Diluting Its Own Stock Helped BICO

Motley Fool StaffJan 7, 2022
bioprinting

How This Swedish MedTech IPO Surged Over 1000%

Motley Fool StaffJan 7, 2022
testing-cream

This Bioconvergence Company Has the Key to End Animal Testing

Motley Fool StaffJan 6, 2022
biotech-research-lab

This Small-Cap Company Is Flipping the Medtech Model on Its Head

Motley Fool StaffJan 6, 2022
research-lab

How This Healthcare Stock Is Pioneering Bio Convergence

Motley Fool StaffJan 6, 2022
biotech

4 X-Factors That Could Send BICO's Stock Soaring

Motley Fool StaffJan 6, 2022

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BICO Group

BICO Group AB (publ) is a global bio-convergence enterprise, specializing in advanced bioprinting and bioautomation technologies. The company operates across multiple international markets, providing innovative solutions to the medical, pharmaceutical, and cosmetic industries.

Products and Services
  • 3D bioprinters and hybrid microscopes for laboratory research
  • Precision dispensing and biosensor technologies for industrial clients
  • Specialized services in tissue engineering and diagnostics
Growth Outlook
  • Revenue increased to SEK 336.1 million in Q2 2026, showing strong demand
  • Gross profit margin improved to 46.8% in Q2 2026, indicating operational efficiency
  • Expansion into new markets is expected to drive future revenue growth
Financial Highlights
  • Net income for Q2 2026 was SEK -37.2 million, reflecting ongoing investments
  • Cash and cash equivalents stood at SEK 627.6 million as of June 30, 2026
  • Current ratio of 2.42 indicates strong liquidity position
BICO Group AB (publ) has established itself as a leader in the bio-convergence sector, with a diverse portfolio that addresses the needs of various industries. The company's Laboratory Solutions division offers cutting-edge tools and consumables, while the Bioautomation segment focuses on precision technologies for industrial applications. Recent financial performance highlights a significant increase in revenue and an improved gross profit margin, suggesting effective management and operational strategies. The company's strong liquidity position, as evidenced by its current ratio, provides a solid foundation for future growth initiatives. As BICO Group continues to expand its market presence and innovate within its product offerings, it remains well-positioned to capitalize on the growing demand for bio-convergence solutions.
AI Generated • Sep 20, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

602

CEO

Maria Ada Eufemia Forss, MBA

Website

bico.com

Headquarters

Gothenburg, VG 412 63, SE

BICO Financials

Key Financial Metrics (TTM)

Gross Margin

45.61%

Operating Margin

-11.37%

Net Income Margin

-55.79%

Return on Equity

-49.84%

Return on Capital

-7.75%

Return on Assets

-29.64%

Earnings Yield

-49.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

SEK 1.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

70.57M

Volume

390.26K

Avg. Volume

316.45K

Financials (TTM)

Gross Profit

SEK 686.00M

Operating Income

-SEK 171.00M

EBITDA

-SEK 1.06B

Operating Cash Flow

SEK 11.30M

Capital Expenditure

-SEK 17.20M

Free Cash Flow

-SEK 5.90M

Cash & ST Invst.

SEK 627.60M

Total Debt

SEK 266.40M

BICO Group Performance Analysis

BICO Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 2,120,800,00068.7%
20232023-12-31SEK 2,010,400,000-5.2%
20242024-12-31SEK 1,727,200,000-14.1%
20252025-12-31SEK 1,497,200,000-13.3%
BICO Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3019.3%
Q42025-12-3116.6%
Q12026-03-31-26.9%
Q22026-06-301.9%
BICO Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK -12.27230.9%
20232023-12-31SEK -16.6235.4%
20242024-12-31SEK -0.08-99.5%
20252025-12-31SEK -15.4319706.2%
BICO Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-231.8%
Q42025-12-3190.3%
Q12026-03-31-121.4%
Q22026-06-3071.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SEK 336.10M

+3.7%

Gross Profit

SEK 157.40M

+10.5%

Gross Margin

46.83%

N/A

Market Cap

SEK 1.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

SEK 3.09M

N/A

Employees

554

N/A

Net Income

-SEK 37.20M

+79.8%

EBITDA

-SEK 32.90M

+21.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SEK 627.60M

-1.4%

Total Debt

SEK 266.40M

-81.1%

Accounts Receivable

SEK 282.00M

-6.3%

Inventory

SEK 207.70M

-11.0%

Long Term Debt

SEK 206.60M

-16.8%

Short Term Debt

SEK 59.80M

-94.8%

Return on Assets

-29.64%

N/A

Return on Invested Capital

-7.30%

N/A

Free Cash Flow

-SEK 61.70M

-95.3%

Operating Cash Flow

-SEK 56.00M

-98.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,659.44-0.01%
^DJIDJI
$52,002.41-0.00%
^IXICNASDAQ
$26,140.03-0.02%
BTCBitcoin
$81,471.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$89.85-5.79%
NVDANvidia
$214.13-1.43%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$93.67-12.74%
CCCCCC Intelligent Solutions
$7.61-0.26%

Questions About BICO

What is the current price of BICO Group?

BICO Group is trading at SEK 24.25 per share.

What is the 52-week range for BICO Group?

Over the past 52 weeks, BICO Group has traded between SEK 12.94 and SEK 25.42.

How much debt does BICO Group have?

As of the most recent reporting period, BICO Group reported total debt of SEK 686.70M.

How much cash does BICO Group have on hand?

BICO Group reported SEK 627.60M in cash and cash equivalents in its most recent financial results.

What is BICO Group’s dividend yield?

BICO Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services